# OnCo record yelena-janjigian (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/yelena-janjigian/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "yelena-janjigian" ;
  schema:name "Yelena Y. Janjigian"@en ;
  schema:description "Led CheckMate 649, which made immunotherapy plus chemotherapy the first-line standard for gastric cancer, and the pembrolizumab-trastuzumab combination in HER2-positive disease."@en ;
  schema:url <https://onco.cc/people/yelena-janjigian/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/doctors/yelena-janjigian>, <https://pubmed.ncbi.nlm.nih.gov/?term=Janjigian%20YY%5BAuthor%5D> ;
  schema:jobTitle "Chief, Gastrointestinal Oncology Service" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/esophageal/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/checkmate-649/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .